Affiliation:
1. Helsinki University Hospital, Skin and Allergy Hospital , Helsinki , Finland
Abstract
We previously conducted a randomized double-blinded clinical cohort study on topical tacrolimus safety issues in 1–3-year-old children with atopic dermatitis. Five years on, the participants were contacted via a postal questionnaire to obtain long-term data. There were no significant differences regarding infections, growth parameters (height, weight, body mass index), quality of life and disease severity between use of topical tacrolimus and topical corticosteroids.
Funder
Finnish Dermatological Society
Publisher
Oxford University Press (OUP)